Senichkin V V, Kopeina G S, Zamaraev A V, Lavrik I N, Zhivotovsky B D
Faculty of Basic Medicine, Lomonosov Moscow State University, Moscow, 119991, Russia.
Department of Translational Inflammation Research, Otto von Guericke University, Magdeburg, 39120, Germany.
Mol Biol (Mosk). 2016 May-Jun;50(3):416-34. doi: 10.7868/S0026898416030101.
The main objective of anticancer treatment is the elimination of degenerated cells by the induction of programmed cell death. Various chemotherapy drugs and radiation are able to activate cell death mechanisms in tumors. However, unfortunately, monotherapy will always be insufficiently effective because of the variety and virulence of tumors, as well as their ability to develop resistance to drugs. Moreover, monotherapy might constrain many negative side effects. Therefore, the combination of different approaches and/or drugs will increase the efficiency of treatment. One such promising approach is the combination of nutrient restriction (NR) and various chemotherapeutic drugs. This approach may not only affect the autophagy but also influence apoptotic cell death. This review is focused on the potential of NR use in anticancer therapy, as well as the molecular mechanisms underlying this approach.
抗癌治疗的主要目标是通过诱导程序性细胞死亡来消除退化细胞。各种化疗药物和辐射能够激活肿瘤中的细胞死亡机制。然而,不幸的是,由于肿瘤的多样性和毒性以及它们产生耐药性的能力,单一疗法的效果总是不够理想。此外,单一疗法可能会带来许多负面副作用。因此,不同方法和/或药物的联合使用将提高治疗效率。一种有前景的方法是营养限制(NR)与各种化疗药物的联合使用。这种方法不仅可能影响自噬,还可能影响凋亡性细胞死亡。本综述聚焦于营养限制在抗癌治疗中的应用潜力及其背后的分子机制。